These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4856045)

  • 1. Distinction between inhibition of purine nucleotide synthesis and the delayed cytotoxic reaction of 6-mercaptopurine.
    Tidd DM; Paterson AR
    Cancer Res; 1974 Apr; 34(4):733-7. PubMed ID: 4856045
    [No Abstract]   [Full Text] [Related]  

  • 2. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine.
    Tidd DM; Paterson AR
    Cancer Res; 1974 Apr; 34(4):738-46. PubMed ID: 4856046
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of methylthioinosine on nucleotide concentrations in L5178Y cells.
    Warnick CT; Paterson AR
    Cancer Res; 1973 Jul; 33(7):1711-5. PubMed ID: 4737232
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of action of 6-thioguanine, 6-mercaptopurine, and 8-azaguanine.
    Nelson JA; Carpenter JW; Rose LM; Adamson DJ
    Cancer Res; 1975 Oct; 35(10):2872-8. PubMed ID: 1157053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
    Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
    Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purine nucleotide metabolism and nucleotide pool sizes in synchronized lymphoma L5178Y cells.
    Snyder FF; Henderson JF; Kim SC; Paterson AR; Brox LW
    Cancer Res; 1973 Oct; 33(10):2425-30. PubMed ID: 4355027
    [No Abstract]   [Full Text] [Related]  

  • 7. Murine lymphoma L5178Y cells resistant to purine antagonists: differences in cross-resistance to thioguanine-platinum(II) and selenoguanine-platinum(II).
    Kanzawa F; Maeda M; Sasaki T; Hoshi A; Kuretani K
    J Natl Cancer Inst; 1982 Feb; 68(2):287-91. PubMed ID: 6950160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical mechanisms for the synergism between 6-thioguanine and 6-(methylmercapto)purine ribonucleoside in sarcoma 180 cells.
    Nelson JA; Parks RE
    Cancer Res; 1972 Oct; 32(10):2034-41. PubMed ID: 4673141
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed cytotoxicity of 6-mercaptopurine is compatible with mitotic death caused by DNA damage due to incorporation of 6-thioguanine into DNA as 6-thioguanine nucleotide.
    Inamochi H; Higashigawa M; Shimono Y; Nagata T; Cao DC; Mao XY; M'soka T; Hori H; Kawasaki H; Sakurai M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):417-24. PubMed ID: 10606189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sulfur containing purine nucleosides on immunological reaction in mice. I. Immunosuppressive effect of several alkylthio, aralkylthio and thiocyanatopurines and their ribonucleosides.
    Sekine T; Arai Y; Saneyoshi M
    Jpn J Exp Med; 1973 Oct; 43(5):369-75. PubMed ID: 4544070
    [No Abstract]   [Full Text] [Related]  

  • 11. Resistance to purine antagonists in experimental leukemia systems.
    Brockman RW
    Cancer Res; 1965 Oct; 25(9):1596-605. PubMed ID: 5323969
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of a human lymphoid cell line to evaluate interactions between prednisolone and other chemotherapeutic agents.
    Norman MR; Harmon JM; Thompson EB
    Cancer Res; 1978 Nov; 38(11 Pt 2):4273-8. PubMed ID: 279403
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of purine nucleotide metabolism by 6-methylthiopurine ribonucleoside and structurally related compounds.
    Shantz GD; Smith CM; Fontenelle LJ; Lau HK; Henderson JF
    Cancer Res; 1973 Nov; 33(11):2867-71. PubMed ID: 4795903
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of 6-mercaptopurine on P32-orthophosphate incorporation into the acid-soluble purine nucleotides of YC1-T20 myeloid tumor (Graffi) in mice].
    Chelibonova-Lorer Kh; Iakimov M; Golovinski E
    Vopr Med Khim; 1973; 19(2):191-3. PubMed ID: 4707510
    [No Abstract]   [Full Text] [Related]  

  • 15. Interference with nucleoside transport in mouse lymphoma cells proliferating in culture.
    Warnick CT; Muzik H; Paterson AR
    Cancer Res; 1972 Oct; 32(10):2017-22. PubMed ID: 4673140
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effects of several inhibitors of the synthesis of nucleic acids upon the viability and progression through the cell cycle of cultured H. Ep. no. 2 cells.
    Wheeler GP; Bowdon BJ; Adamson DJ; Vail MH
    Cancer Res; 1972 Dec; 32(12):2661-9. PubMed ID: 4264728
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular mechanisms underlying the enhanced sensitivity of thiopurine-resistant T-lymphoblastic cell lines to methyl mercaptopurineriboside.
    Fotoohi AK; Wrabel A; Moshfegh A; Peterson C; Albertioni F
    Biochem Pharmacol; 2006 Sep; 72(7):816-23. PubMed ID: 16859645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [African green monkey cell line RAMP simultaneously resistant to 8-azaguanine, 6-mercaptopurine, and 6-thioguanine].
    Stobetskiĭ VI; Grachev VP; Mironova LL; Chernikov VG
    Biull Eksp Biol Med; 1982 Oct; 94(10):113-5. PubMed ID: 6890862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formal discussion on resistance to purine antagonists in experimental leukemia systems.
    Davidson JD
    Cancer Res; 1965 Oct; 25(9):1606-7. PubMed ID: 5217557
    [No Abstract]   [Full Text] [Related]  

  • 20. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.